TCL Archive Insurer Declines To Cover Avastin For Breast Cancer, Institutes Review Procedure For Exceptional Cases October 21, 2011
TCL Archive Phase II Study Meets Primary Endpoint, Demonstrating Overall Survival of 5.2 Months September 27, 2013
TCL Archive Lasagna Committee Report Advocates Faster Drug approval, Insurance Coverage For Investigational Drugs, Ancillary Costs September 7, 1990
TCL Archive Senate confirms McClellan to head CMS. NCI “redeploys” $54.5 million cut from divisions to fund strategic initiatives. March 26, 2004
